phase

GENESIS MOTOR EUROPE ANNOUNCES MAXIMILIAN KALBFELL AS NEW HEAD OF MARKETING

Genesis Motor Europe strengthens its executive team, with the appointment of Maximilian KalbfellBringing over 20 years of marketing experience, Maximilian…

2 months ago

Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT for Parkinsons Disease

December 05, 2025 08:00 ET  | Source: Amneal Pharmaceuticals LLC Interim data show substantial improvements in “Good On” time compared…

2 months ago

NobleAI Appoints Alex Wang as Chief Executive Officer to Lead Next Phase of Growth and Innovation

SAN FRANCISCO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- NobleAI, the leader in practical AI solutions for chemistry and energy, announced…

2 months ago

Plume Appoints Lorie Boyd as Chief People Officer

Boyd brings deep HR and workforce management experience from Turo and Zendesk to help Plume scale through next phase of…

2 months ago

Yatra Strengthens Leadership for Next Phase of Growth

Elevates Co-Founder Dhruv Shringi to Executive Chairman; Appoints Siddhartha Gupta as CEONEW DELHI, Nov. 25, 2025 /PRNewswire/ -- Yatra Online…

3 months ago

InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis

BEIJING, Nov. 27, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the…

3 months ago

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting

November 26, 2025 19:00 ET  | Source: HUTCHMED (China) Limited HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 27,…

3 months ago

Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate

Antibody levels remained well above baseline across all six serotypes and age groups sixth month after third yearly booster doseNo…

3 months ago

Alzheimer’s Association Statement on Oral Semaglutide Phase 3 Topline Data Release

- Results Underscore Need for Continued Research and Diverse Treatment PipelineCHICAGO, Nov. 24, 2025 /PRNewswire/ -- The Alzheimer's Association is disappointed…

3 months ago

MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025

Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as expansion trial adds new countries Posters for Phase…

3 months ago